Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06027437 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT06027437 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 21 participants.
The verdict
NCT06027437, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the relative biological availability and the effect of food on the drug levels of Danicamtiv in health adults.
Interventions
- DRUG Danicamtiv
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2023-09-05 |
| Est. Completion | 2023-11-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06027437
The ClinicalTrials.gov registry entry for NCT06027437 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Danicamtiv is the first listed.
NCT06027437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06027437 about?
NCT06027437 is a clinical study titled "A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants". The purpose of this study is to assess the relative biological availability and the effect of food on the drug levels of Danicamtiv in health adults.
What is the current status of trial NCT06027437?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2023-09-05. Estimated completion is 2023-11-10.
What interventions are being tested in trial NCT06027437?
The interventions under investigation include: Danicamtiv (DRUG).
Who is sponsoring clinical trial NCT06027437?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.